IRGM in autophagy and viral infections by Denitsa S. Petkova et al.
“ﬁmmu-03-00426” — 2013/1/12 — 17:53 — page 1 — #1
MINI REVIEW ARTICLE
published: 17 January 2013
doi: 10.3389/ﬁmmu.2012.00426
IRGM in autophagy and viral infections
Denitsa S. Petkova, ChristopheViret and Mathias Faure*
Laboratory of Autophagy, Infections and Immunity, INSERM, U1111, CIRI, Université Lyon 1, Lyon, France
Edited by:
Christian Muenz, University of Zurich,
Switzerland
Reviewed by:
Philippe Pierre, Centre National de La
Recherche Sceintiﬁque, France
John D. MacMicking, Yale University
School of Medicine, USA
*Correspondence:
Mathias Faure, Laboratory of
Autophagy, Infections and Immunity,
INSERM, U1111, CIRI, Université Lyon
1, 21 AvenueTony Garnier, 69365
Lyon Cedex 07, France.
e-mail: mathias.faure@inserm.fr
Autophagy is a cell autonomous process allowing each individual cell to ﬁght intracellular
pathogens. Autophagy can destroy pathogens within the cytosol, and can elicit innate and
adaptive immune responses against microorganisms. Nevertheless, numerous pathogens
have developed molecular strategies enabling them to avoid or even exploit autophagy for
their own beneﬁt. IRGM (immunity-related GTPase family M) is a human protein recently
highlighted for its contribution to autophagy upon infections. The physical association
of IRGM with mitochondria and different autophagy-regulating proteins, ATG5, ATG10,
SH3GLB1, and LC3, contribute to explain how IRGM could regulate autophagy. Whereas
IRGM is involved in autophagy-mediated immunity against bacteria, certain viruses seem to
have developed strategies to manipulate autophagy through the selective targeting of this
protein. Furthermore, irgm variants are linked to infection-associated human pathologies
such as the inﬂammatory Crohn’s disease. Here, we discuss how IRGM might contribute
to human autophagy upon viral infection, and why its targeting might be beneﬁcial to virus
replication.
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INTRODUCTION
As obligatory intracellular parasites, viruses are continually faced
with the degradative mechanism of macroautophagy (thereafter
referred to as autophagy; Figure 1). Autophagy can destroy infec-
tious virions or virus components that are essential for replication
(Levine, 2005; Richetta and Faure, 2012). Furthermore, autophagy
can deliver viral genomes to TLR-containing endosomes, which
sets off synthesis of antiviral type I interferon (IFN-I; Lee et al.,
2007). Autophagy can also contribute to virus-derived peptide
presentation on class I and class II major histocompatibility com-
plex (MHC) molecules to trigger antiviral CD8+ and CD4+ T
cells responses, respectively (English et al., 2009; Munz, 2009).
Thus, autophagy is an intrinsic cellular antiviral process able to
enhance innate responses and to link them to adaptive immunity
to optimize the ﬁght against viruses.
Numerous viruses havedevelopedmolecular strategies to coun-
teract autophagy. Certain viruses developed properties enabling
them to inhibit the autophagy ﬂux. For instance, herpes sim-
plex virus (HSV)-1 or the cytomegalovirus (CMV) can inhibit
autophagy induction by targeting BECLIN1 (BECN1), an essen-
tial autophagy-associated protein, through interactions with viral
proteins (Orvedahl et al., 2007; Chaumorcel et al., 2012). Other
viruses avoid autophagy degradation by inhibiting autophago-
somematuration such as human immunodeﬁciency virus (HIV)-1
and inﬂuenza A virus which prevent autophagosome matura-
tion through the physical interaction of one viral protein with
BECN1 (Gannage et al., 2009; Kyei et al., 2009). Finally, viruses
can induce a complete productive autophagy process and exploit
it as a source for metabolites or as a platform for improving their
own replication (Jackson et al., 2005; Heaton and Randall, 2010).
Thus, host-virus co-evolution may have led to the selection of
very different mechanisms used by viruses to avoid or exploit
autophagy.
The understanding of the molecular pathways linked to the
proviral or antiviral functions of autophagy is still at its beginning,
especially regarding the molecular interplay between viruses and
autophagy proteins. The human immunity-related GTPase fam-
ily M (IRGM) protein was shown to be widely targeted by RNA
viruses, several amongwhich can exploit autophagy in human cells
to improve their replication (Gregoire et al., 2011, 2012). How-
ever, how IRGM regulates autophagy upon infections remains
unknown. This aspect might be of great interest in several human
pathologies for which irgm was recently found to be involved.
IRGM AND AUTOPHAGY IN INFECTIONS
Unlike its mouse ortholog, the human irgm gene expression is
not under the control of IFN-γ (Bekpen et al., 2005). Whereas 23
immune-related genes (irg) genes exist in mice and play immune-
related functions, the IRGM-mediated cell autonomous resistance
mechanisms have been ﬁrst lost in primates due to deleterious
mutations. However, irgm gene function was restored in some pri-
mates including Homo sapiens, possibly due to the insertion of
a retroviral element that promotes its expression (Bekpen et al.,
2009). In human, ﬁve different IRGM splice isoforms that differ
in their C-terminal ends could be expressed, but their individ-
ual endogenous expression has not yet been documented (Bekpen
et al., 2005; Singh et al., 2010); endogenous IRGM as well as over-
expressed IRGMd isoform can localize in mitochondria (Singh
et al., 2010; Gregoire et al., 2011).
One of the ﬁrst molecular demonstrations of a role of
autophagy in immune responses against intracellularmicroorgan-
isms, involved the murine ortholog of IRGM, IRGM1 (Gutier-
rez et al., 2004), previously described to be involved in the
vacuolar trafﬁcking of phagosomes containing Mycobacterium
tuberculosis (MacMicking et al., 2003). M. tuberculosis entrapped
within phagosomes can avoid its destruction by preventing
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FIGURE 1 | General steps of mammalian autophagy. Autophagy engulfs
portions of the cytosol through three main steps. The nucleation induces the
formation of an isolation membrane which could emerge from different
membrane sources (the endoplasmic reticulum, the Golgi apparatus, the
plasma membrane, the mitochondria) to form a phagophore which elongates
to form double-membraned autophagosome vesicles. Autophagosome can
sequester cytosolic material including senescent organelles such as
mitochondria, long-lived proteins or intracellular pathogens, through
independent selective autophagies (for schematic simpliﬁcation, all were
represented within one single autophagosome). Autophagosome ultimately
fuses with lysosomes during the maturation step to form autolysosomes
where degradation occurs. Some of the crucial proteins involved in the
different phases of autophagy are indicated. Several viruses can induce a
complete autophagy ﬂux, as MeV or ChikV, whereas others can inhibit
autophagosome maturation, as HIV-1 and HCV, in order to improve their
replication (see text for details).
phagosome fusion with lysosomes but the rerouting of M.
tuberculosis-containing phagosomes to the autophagic machin-
ery can ultimately degrade the bacteria. The treatment of murine
macrophages with IFN-γ induces autophagy via IRGM1 and pro-
tects from M. tuberculosis (Gutierrez et al., 2004; Singh et al.,
2006). IRGM-mediated autophagy also contributes to protection
in human cells against intracellular M. tuberculosis, Escherichia
coli, and Salmonella typhimurium (Singh et al., 2006; McCarroll
et al., 2008; Lapaquette et al., 2010; Brest et al., 2011). The fact that
there appears to be no role for IRGM or for its murine ortholog
IRGM1 in the regulation of autophagy in absence of infection sug-
gests a pathogen-speciﬁc function in autophagy for these proteins
(Gregoire et al., 2011; Matsuzawa et al., 2012).
IRGM IN VIRUS-MEDIATED AUTOPHAGY
IRGM IS A COMMON TARGET OF RNA VIRUSES
RNA viruses genome encodes very few proteins including non-
structural proteins that are often dedicated to prevent antiviral
responses (Katze et al., 2008). To optimize replication, individ-
ual viral proteins could target several different host-cell proteins
to counteract cellular antiviral responses. Alternatively, viral pro-
teins could be dedicated to the efﬁcient targeting of few host-cell
proteins to counteract essential biological functions. The analy-
sis of the interactions between 44 autophagy-associated human
proteins and 83 viral proteins belonging to different RNA virus
families revealed IRGMas themost targeted autophagy-associated
protein by these viruses. IRGM can interact with 12 viral proteins
belonging to ﬁve different viruses, Chikungunya virus (ChikV),
Mumps virus (MuV), Hepatitis C virus (HCV), Measles virus
(MeV), and HIV-1 (Gregoire et al., 2011). Except for MuV for
whom no autophagy-related studies were yet reported, all other
viruses manipulate autophagy.
IRGM AND VIRUSES EXPLOITING THE AUTOPHAGY FLUX
Measles virus infection increases the formation of de novo
autophagosomes by inducing the autophagy ﬂux (Figure 1; Jou-
bert et al., 2009;Meiffren et al., 2010; Gregoire et al., 2011). Genetic
inhibition of autophagy limits MeV viral particles production,
indicating that MeV exploits autophagy to replicate. The reduced
expression of cellular IRGM with speciﬁc siRNA decreased MeV
replication in HeLa cells. Furthermore, the non-structural MeV-
C protein can interact with IRGM, and its single overexpression
induces autophagy through an IRGM-dependent pathway (Gre-
goire et al., 2011). Thus, in the course of MeV infection, the
MeV-C/IRGM interaction might contribute to the exploitation
of autophagy by MeV.
Chikungunya virus infection also induces the autophagy ﬂux
(Figure 1; Krejbich-Trotot et al., 2011; Joubert et al., 2012).
Whereas inhibition of autophagy limits ChikV viral particles pro-
duction, the experimental promotion of autophagy improved
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its replication (Krejbich-Trotot et al., 2011). ChikV replication
is required to induce autophagy upon infection, and, as a
consequence, autophagy delays cell death, which limits ChikV-
associated pathogenesis, but favors its dissemination (Joubert
et al., 2012). ChikV infection induces endoplasmic reticulum and
oxidative stresses that independently can trigger autophagy (Jou-
bert et al., 2012). However, it is unknown whether ChikV proteins
contribute directly to autophagy induction and/or maintenance
in infected cells. Especially, IRGM was found to interact with
ChikV-NS2 and E3 proteins (Gregoire et al., 2011). It will be inter-
esting to determine whether ChikV/IRGM interaction contributes
to autophagy manipulation.
IRGM AND VIRUSES INHIBITING AUTOPHAGY MATURATION
During HIV-1 infection, autophagy manipulation strategies
depend on the type of infected cells. The exposition of HIV-1-ENV
protein onmembranes of infected cells induces autophagy inunin-
fected CD4+ T cells leading to their apoptotic cell death (Espert
et al., 2006). However,HIV-1 inhibits autophagy in infected CD4+
T cells, which facilitates replication (Espert et al., 2009). In den-
dritic cells (DC), HIV-1 inhibits autophagy through exhaustion
of the mTOR signaling pathway (Blanchet et al., 2010). How-
ever, autophagy is induced in HIV-1-infected macrophages where
HIV-1–NEF protein can interact with BECN1 to inhibit the mat-
uration of autophagosomes, what is required for an efﬁcient
replication of HIV-1 (Espert et al., 2009; Kyei et al., 2009). NEF
can also interact with IRGM and the overexpression of NEF
induces an IRGM-dependent accumulation of autophagosomes
(Kyei et al., 2009; Gregoire et al., 2011). Thus, while NEF–BECN1
interaction could prevent autophagosome maturation, NEF–
IRGM interaction could be involved in autophagy induction upon
HIV-1 infection in macrophages. Through its interaction with
distinct autophagy-associated proteins, a unique HIV-1 protein
could ﬁnely regulate autophagy. Interestingly, a NEF deﬁcient
strain of HIV-1 does not induce autophagosome accumulation,
suggesting indeed that, besides preventing autophagosome matu-
ration, NEF is involved in the induction of autophagy by HIV-1
(Kyei et al., 2009).
Infection by HCV also induces autophagy. This induction is
independent of mTOR (Su et al., 2011; Shrivastava et al., 2012),
and the contribution of the unfolded protein response remains
unclear (Sir et al., 2008; Mohl et al., 2012). However, autophagy
is required for an optimal HCV replication since inhibition of
autophagy affects HCV replication (Dreux et al., 2009; Tanida
et al., 2009; Gregoire et al., 2011). Reports have shown that HCV
infection could either induce a complete autophagy ﬂux or inhibit
autophagosome maturation. This discrepancy might result from
the models used and/or the kinetics of infection. HCV infection
was shown to prevent autophagosome maturation at an early
time of infection (Sir et al., 2008; Gregoire et al., 2011; Su et al.,
2011). At a later one a complete autophagy ﬂux was reported
(Ke and Chen, 2011; Mohl et al., 2012). Interestingly, a subge-
nomic replicon expressing the non-structural NS3-5B proteins
induces autophagy (Mohl et al., 2012). Furthermore, IRGM can
interact with HCV-NS3, and the reduced expression of IRGM
prevents HCV-induced and HCV-NS3-induced autophagy, and
limits HCV replication (Gregoire et al., 2011).
Thus, viruses that manipulate autophagy either by beneﬁting
from the complete autophagy ﬂux or by inhibiting the maturation
step, target IRGM. Beyond its role in virus biology, how IRGM
contributes to the orchestration of autophagy upon viral infection
remains to be understood.
IRGM IN AUTOPHAGY INDUCTION UPON VIRAL INFECTIONS
IRGM AND AUTOPHAGY-ASSOCIATED PROTEINS
To date, only four cellular proteins were identiﬁed to interact with
IRGM: ATG5, ATG10, MAP1LC3C, and SH3GLB1 (Figure 2). All
these proteins contribute to autophagy, supporting the idea that
IRGM plays an essential role in this process (Gregoire et al., 2011).
ATG10, a conjugating E2-like protein, contributes to the assem-
bly of the ATG12/ATG5 complex that binds ATG16L1 to form
macromolecular ATG12/ATG5/ATG16L1 complexes essential for
the elongation of the phagophore (Figure 1; Xie and Klionsky,
2007). MAP1LC3C is a member of theMAP1LC3 (known as LC3)
sub-family and is also required for elongation of the phagophore
through lipidationwith phosphatidylethanolamine and anchoring
within the extending phagophore (Figure 1;Weidberg et al., 2010).
Finally, SH3GLB1 (also known as Bif-1) is a positive regulator of
thenucleationprocess that initiates autophagosome formation, via
its interaction with UVRAG, a protein of the BECN1/VPS34 com-
plex. In nutrient deprived cells, SH3GLB1 colocalizes with ATG5
and LC3 to the autophagosome and potentiates the activation
of the class III PI(3)-kinase VPS34 to promote autophagosome
biogenesis (Figure 2; Takahashi et al., 2007). Thus, all the pro-
teins known to interact with IRGM regulate one of the initial
steps of autophagosome biogenesis, suggesting that IRGM might
contribute to the nucleation and/or the elongation of autophagic
vesicles through its interaction with one or several of these pro-
teins. These interactions could be facilitated upon viral infection
(Figure 2). Through the dampening of antiviral IFN-I synthesis,
this targeting might be of further beneﬁt to viruses as discussed
below.
IRGM, MITOCHONDRIA, AUTOPHAGY, AND IFN-I IN VIRAL INFECTIONS
OverexpressedGFP-fused IRGMdwas suggested to be translocated
to the inner membrane of mitochondria via its association with
cardiolipin (CL; Singh et al., 2010). CL is a phospholipid abun-
dant in the inner mitochondrial membrane that is however also
found in the outer membrane and at the contact sites between the
two membranes (Schlame et al., 2000; Schug and Gottlieb, 2009).
Thus IRGMd might also be associated to CL linked to the outer
membrane of mitochondria, and exposed to the cytosol. The four
other overexpressed GFP-fused IRGM isoforms (IRGMa/b/c/e)
were not found associated to mitochondria (Singh et al., 2010).
However, endogenous IRGM expression, detected with an anti-
bodywith putative ability to recognize all IRGM isoforms, is found
associated to mitochondria suggesting that: (i) all endogenous
IRGM can be located to mitochondria, (ii) IRGMd is the most
expressed isoform, or (iii) due to possibly distinct folding among
the isoforms, the epitope for the antibody is only accessible on
IRGMd (Figure 2; Singh et al., 2010; Gregoire et al., 2011). Inter-
estingly, among the proteins interacting with IRGM at least two
were found partially associated with mitochondria, SH3GLB1 and
ATG5. A fraction of SH3GLB1 localizes to mitochondria where
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FIGURE 2 | Hypothetical regulation of autophagy by IRGM upon
viral infections. IRGM is associated to mitochondria via cardiolipin (CL).
Upon viral infection, IRGM could interact with four different autophagy-
associated proteins which could support autophagosome biogenesis from
mitochondria membrane, by regulating nucleation and/or elongation steps
of autophagy. IRGM-mediated autophagy might correlate to a decrease of
IFN-I synthesis similarly to what was described for TUFM and MFN2. Both
processes could beneﬁt to viruses to improve their replication.
Note that MFN2-mediated autophagy has not yet been reported
in the context of viral infection (see text for details). As represented,
viral double-stranded (ds)RNA can be recognized by RIG-I. IFN-I
inhibition via IRGM is not yet demonstrated (dashed line) and
putative not mitochondrial IRGM isoforms are not represented
(see text for details).
it may contribute to the regulation of morphological dynamics
of the outer mitochondrial membrane (Karbowski et al., 2004),
and to mitochondria-dependent apoptotic signals by interact-
ing with the proapoptotic protein BAX (Takahashi et al., 2005).
ATG5 was also shown to associate with mitochondria through
its binding to IPS-1, a mitochondria-associated adaptor which
relays signals from viral genome-detecting cytosolic receptors
RIG-I and MDA5, in order to promote IFN-I synthesis. This
interaction contributes to the down-regulation of IFN-I pro-
duction during viral infection (Jounai et al., 2007). A possible
hypothesis for the molecular contribution of IRGM in autophagy
would be that IRGM interacts/recruits its protein partners at
the mitochondria to induce autophagy upon infections espe-
cially as mitochondria is one possible source of membrane for
autophagosome biogenesis (Figures 1 and 2; Hailey et al., 2010).
Furthermore, the IRGM targeting to mitochondria could allow
viruses to limit IFN-I production similarly to two other mito-
chondrial proteins, MFN2 and TUFM, which were shown to
dampen IFN-I production while inducing autophagy (Figure 2).
Indeed, MFN2 contributes to the supply of mitochondria mem-
branes for the biogenesis of autophagosome (Hailey et al., 2010),
and can down-regulate the production of IFN-I upon viral infec-
tion by interacting with IPS-1 (Yasukawa et al., 2009). Similarly,
TUFM recruits the ATG5/ATG12 complex in order to induce
autophagy, while it prevents RIG-1/IPS-1 signal transduction for
IFN-I production via its interaction with NLRX1 (Lei et al., 2012).
The antagonistic activities of TUFM and MFN2 on autophagy
and IFN-I production were shown to beneﬁt to virus replication
(Yasukawa et al., 2009; Lei et al., 2012). As IRGM is associated
to mitochondria and modulates autophagy induction upon virus
infection, it would be important to evaluate its contribution to
the ability of viruses to dampen IFN-I production; all the viruses
described to date to target IRGM are known to inhibit IFN-
I production. Thus, different mitochondrial proteins, including
IRGM,might have dual functions upon virus infection, by induc-
ing autophagy ultimately exploited by viruses, while restricting
the innate antiviral response; the selective targeting of these pro-
teins would offer an evident advantage for infectious viruses to
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replicate within a cell. It remains however possible that cytosolic
isoforms of IRGM contributes to autophagy induction upon viral
infection.
IRGM AND AUTOPHAGY-MEDIATED VIRUS-DERIVED PEPTIDE MHC
LOADING
It recently became clear that autophagy which is constitutively
active in antigen-presenting cells (APCs), can regulate adaptive
immune responses by promoting the access of antigens from intra-
cellular pathogens to compartments that assemble peptide:MHC
class II complexes for presentation to CD4+ T cells (Munz, 2009).
Among viruses targeting IRGM, it was observed that the response
of HIV-1 gag-speciﬁc CD4+ T cells to DC that process the virus
was drastically reduced upon either pharmacological or genetic
inhibition of autophagy, indicating a deﬁcient capacity to process
and present MHC class II-restricted HIV-1 determinants when
autophagy is impaired (Blanchet et al., 2010). The negative regu-
lation of autophagy in DCs by HIV-1 could thus help the virus
evade CD4+ T cell responses. As to presentation by MHC class I
molecules, it is known that in mouse DCs, IRGM3/IGTP (another
murine ortholog or IRGM) plays an important role in cross-
presentation of phagocytosed protein antigens to conventional
CD8+ T cells without impacting antigen presentation to CD4+
T cells (Bougneres et al., 2009).
irgm VARIANTS IN HUMAN PATHOLOGIES AND VIRAL
INFECTIONS
Recent studies identiﬁed irgm variants as susceptibility genes
for Crohn’s disease (CD), tuberculosis (TB), gastric cancer and
autoimmune systemic lupus erythematosus (SLE).
IRGM, CD, AND VIRAL INFECTION
Crohn’s disease is a chronic inﬂammatory bowel disease resulting
from an aberrant immune response toward the intestinal ﬂora that
leads to inﬂammation and tissue damages (Xavier et al., 2008).
Genome-wide association studies identiﬁed polymorphisms in
two autophagy-associated genes, atg16L1 and irgm, that are linked
to CD. CD-associated irgm polymorphisms, that inﬂuence or
not the primary protein sequence, were both reported (Parkes
et al., 2007; McCarroll et al., 2008; Moon et al., 2012). Inter-
estingly, the gut mucosa of CD patients harbors an increased
amount of the pathogenic Adherent-invasive E. coli (AIEC) and
IRGM-dependent autophagy contributes to ﬁght pathogenicAIEC
(Lapaquette et al., 2012). Moreover, microRNA (miR)-196 binds
strongly the irgm protective haplotype, whereas expression of the
risk haplotype remains intact thus leading to overall deregulation
of IRGM expression (Brest et al., 2011). miR-196 was found over-
expressed in inﬂamed ileum and colon of patients, independently
of the protective or risk irgm haplotype. As a result, IRGMwas less
expressed in individuals with the protective genotype. Further-
more, the transfection of HEK293T cells with miR-196 resulted in
a decreased autophagy ﬂux, indicating thatmiR-196 acts as a nega-
tive regulator of autophagy via IRGMuponAIEC infection. These
studies suggested that the cornerstone of autophagy regulation by
IRGM upon infection could be its ﬁne tuned level of expression.
Interestingly, a viral infection-plus-susceptibility autophagy
gene interaction could contribute to the onset of CD. Indeed, the
hypomorphic expression of atg16l1 develops a CD-like pathology
inmice only upon infectionwith a viral strain of murine norovirus
(Cadwell et al., 2010). This study pointed toward a genotype-
speciﬁc viral trigger of a pathology very similar to CD. It would be
interesting to investigate the role of viral infections in irgm variant
expressing CD patients, for a possible contribution of virus/IRGM
interactions in the onset or the development of CD.
IRGM IN TB, GASTRIC CANCER, AND SLE
As mentioned above, IRGM contributes to the control of M.
tuberculosis in macrophages via autophagy. Interestingly, an irgm
polymorphism protects from TB caused by Euro-American sub-
groups of M. tuberculosis (Intemann et al., 2009). It was proposed
that when the polymorphism occurs, IRGM is more expressed
resulting in enhanced autophagy and explaining a more efﬁcient
destruction of bacteria. Conversely, several different polymor-
phisms in the irgm gene have been found to result in an increased
susceptibility to TB in Chinese and African American popula-
tions (Che et al., 2010; King et al., 2011). In African American
populations one CD-related polymorphism was associated pos-
itively with TB suggesting a possible link between CD and an
infectious etiology. Irgm polymorphism is possibly also a risk
factor for gastric cancer (Burada et al., 2012). Although deregu-
lation of autophagy is well established to be associated with cancer
(White, 2012), a role for IRGM in these diseases has to be further
determined. Similarly, a genetic-association study suggested that
irgm variants are linked to SLE, an autoimmune disease (Zhou
et al., 2011). A role of IRGM in these diseases remains to be fully
depicted as well as a potential inﬂuence of viral infections on
such role.
CONCLUSION
In an infected cell a virus has to counteract cell autonomous
defense mechanisms while exploiting elementary cellular pro-
cesses to replicate efﬁciently. By selectively targeting autophagy,
viruses might accomplish both. As discussed here, IRGM could
be a key protein for autophagy manipulation upon viral infection.
The molecular organization involving IRGM in autophagy during
viral infections requires further investigations. While interactions
of IRGM with its protein partners were only observed in trans-
fected cells for the time being, it would be important to visualize
these interactions between endogenous proteins and during pro-
ductive infections. It would also be crucial to understand why and
how IRGM plays an antibacterial function, whereas it seems to act
as a proviral factor. Furthermore, the role of IRGM could be cell
type-speciﬁc and, as described for several autophagy-related pro-
teins, IRGM might have non-autophagy-related functions upon
infections. In regards of the link of numerous irgm variants with
human pathologies, the comprehension of the role(s) of IRGM in
autophagy-mediated immunity could be of crucial importance to
ﬁght infectious viruses and human pathologies.
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